Share
Archives
The Ozempic Pill Has a Ceiling — New Trial Proves It
New clinical trial data on orforglipron reveals a biological ceiling that every person on GLP-1 medications needs to understand. I’m breaking down the ATTAIN-MAINTAIN trial findings, explaining what the 15% threshold means for long-term weight management, and identifying exactly who is — and isn't — a strong candidate for the...
Read More
Reducing Your Zebound Dose Could Undo ALL Your Progress
The SURMOUNT MAINTAIN trial has delivered the most compelling evidence yet that obesity requires long-term management — not a finish line. New data reveals exactly what happens to your results at every dose decision, and the numbers make the choice undeniable.
Read More
The Retatrutide Paradox: Why This “Triple Threat” Works
Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.
Read More
Retatrutide TRIUMPH-1 Results: 28% Weight Loss
TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I'm breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.
Read More
Slow Weight Loss on GLP-1s? This Is Why
Most people on Wegovy aren't rapid responders — and the viral 28% weight loss headline from the STEP UP trial only tells half the story. Learn my 4-step Steady-Winner Strategy designed for the 70% who are playing the long game.
Read More
Your #1 Mistake When Taking Ozempic
Discover why the most common weight loss approach — cutting calories, carbs, and joy — is actually triggering your brain's ancient famine alarm and working against your GLP-1 medication. I break down my counterintuitive Stack & Add Plan: five steps that work with your biology to protect muscle, outsmart metabolic...
Read More
Foundayo: The New GLP-1 Pill
Foundayo (orforglipron) is the first oral GLP-1 medication approved for weight loss — but the clinical trial data reveals a meaningful efficacy gap compared to current injectable options. I break down the ATTAIN-1 trial results, the liver metabolism factor most reviews miss, and my practical framework for deciding whether to...
Read More
BPC‑157 & TB‑500 vs Ozempic: The Truth About “Healing Peptides”
Healing peptides like BPC-157 and TB-500 are being marketed as the cutting-edge, natural alternative to GLP-1 medications — but the clinical reality tells a very different story. I break down the Buy-In Effect, the real safety risks of unregulated peptides, and four evidence-based steps that actually protect your progress.
Read More
GLP-1 Side Effects: Why You’re Sick (And How to Fix It)
GI side effects on Wegovy or Zepbound are not proof the medication is working — they're a signal your protocol needs adjusting. My 6-step GI Stability Protocol will give you a concrete, pharmacist-backed framework to manage nausea and stop the guesswork.
Read More
Ozempic Personality – Your Brain On GLP-1s
You did the hard work, the medication is working, the scale is moving — but somewhere along the way, your joy went quiet. The science behind emotional flattening on GLP-1 medications is real, it's validated, and most importantly, it's fixable.
Read More